<!DOCTYPE html>
<html>
    <head>
        <meta charset="utf-8">
<meta http-equiv="X-UA-Compatible" content="IE=edge"/>
        <script src='echarts.min-4.8.0.js'></script>
        <script src='echarts-wordcloud.min.js'></script>
    </head>
    <body>
        <style>
            html, body, #main {
                width: 100%;
                height: 100%;
                margin: 0;
            }
        </style>
        <div id='main'></div>
        <script>
            var chart = echarts.init(document.getElementById('main'));
            var keywords = {"Resveratrol":1,
"chemopreventive agent":1,
"human cancers":1,
"ER":1,
"MED12":1,
"NAB2-STAT6":1,
"E-cadherin":1,
"Sanger sequencing":1,
"fibroadenoma":1,
"immunohistochemistry":3,
"pulmonary adenofibroma":1,
"solitary fibrous tumour":1,
"Breast cancer":6,
"HER2":1,
"HER4":1,
"L-Dopa decarboxylase":1,
"TAAR1 (trace amine-associated receptor 1)":1,
"Trace amines":1,
"4D-computed tomography":1,
"glottic cancer":1,
"larynx motion":1,
"magnetic resonance imaging":1,
"volumetric modulated arc radiotherapy":1,
"meta-analysis":5,
"solid tumor":2,
"tumor-infiltrating tryptase+ mast cells":1,
"unfavorable outcome":1,
"PKM1":2,
"PKM2":4,
"endometrial cancer":1,
"immunostaining":1,
"pyruvate kinase":1,
"receiver operating characteristic curve":1,
"sensitivity":1,
"specificity":1,
"Cofilin 1":1,
"LIM domain kinase 1":1,
"Metastasis":7,
"MiR-519d-3p":1,
"Proliferation":4,
"Adrenal lymphomas":1,
"Pituitary hematological neoplasia":1,
"Thyroid lymphomas":1,
"Cushing disease":1,
"acromegaly":2,
"adrenocorticotrophin (ACTH)":1,
"anterior pituitary":1,
"clinical chemistry":1,
"growth hormone (GH)":1,
"prolactin":1,
"secretory tumors":1,
"thyroid-stimulating hormone (TSH)":1,
"camera-based neck uptake":1,
"differentiated thyroid carcinoma":3,
"radioiodine":2,
"thyroid uptake probe":1,
"AMPK":1,
"Ailanthone (AIL)":1,
"MicroRNA-148a":1,
"Migration":2,
"Wnt/β-catenin":1,
"Epithelial–mesenchymal transition":1,
"Gastric cancer":2,
"Hypoxia":1,
"PCGEM1":1,
"SNAI1":1,
"adolescent/young adult":1,
"cancer":4,
"employment":1,
"finances":1,
"survivorship":1,
"Biopsy":4,
"Guidelines":1,
"Fine needle aspiration biopsy":1,
"Thyroid nodules":7,
"Ultrasound":8,
"DCE-MRI":1,
"lymphovascular invasion":1,
"preoperative prediction":1,
"radiomics":3,
"Core-needle biopsy":1,
"Fine-needle aspiration":7,
"Thyroid carcinoma":12,
"Thyroid nodule":15,
"Lymphatic vessel invasion":1,
"Prognosis":10,
"Twist":1,
"VEGF-C":1,
"alpha therapy":1,
"ascorbic acid":1,
"astatine":1,
"sodium iodide symporter":1,
"thyroid cancer":31,
"Ablation techniques":1,
"Recurrence":4,
"Treatment outcome":1,
"Ultrasonography":3,
"Lymph nodes":1,
"Multislice computed tomography":1,
"Papillary thyroid cancer":6,
"Disease risk":1,
"Healthy longevity":1,
"Quality of life":2,
"Single nucleotide polymorphism":1,
"Somatic mutation":1,
"Triple negative breast cancer":1,
"caspase 9":1,
"diagnosis":3,
"lncRNA POU3F3":1,
"BRAF V600E antibody (clone VE1)":1,
"cell block":1,
"fine needle aspiration":5,
"papillary thyroid carcinoma":20,
"Brown tumors":1,
"Hyperparathyroidism-jaw tumor syndrome":1,
"Parathyroid carcinoma":1,
"Motility":2,
"PPP2CA":1,
"miR-650":1,
"anaplastic thyroid carcinoma":2,
"clear cell variant":1,
"histopathology":4,
"Goiter":3,
"Hyperthyroidism":3,
"Hypothyroidism":3,
"Thyroid ultrasound":2,
"Sendai virus":1,
"oncolytic virus":1,
"urokinase-type plasminogen activator":1,
"virotherapy":1,
"Cytology":7,
"TEP":1,
"TKI":1,
"biologics":1,
"laryngectomy":1,
"prosthesis":1,
"thyroidectomy":4,
"tracheoesophageal fistula":1,
"tyrosine kinase inhibitor":1,
"wound healing":1,
"BRAF":3,
"PPAR gamma":1,
"RAS":2,
"fine needle":2,
"genes":1,
"mutation":3,
"prevalence":1,
"retrospective studies":1,
"thyroid neoplasms":8,
"high tumor burden":1,
"lenvatinib":3,
"multitarget kinase inhibitors":1,
"radioiodine-refractory differentiated thyroid cancer":1,
"tumor growth parameters":1,
"EWSR1":1,
"NR4A3":1,
"TAF15":1,
"axon guidance":1,
"extraskeletal myxoid chondrosarcomas":1,
"sarcoma":1,
"transcriptional profile":1,
"RCC":1,
"TLFCK":1,
"renal cell carcinoma":1,
"sarcomatoid":1,
"thyroid-like follicular carcinoma of the kidney":1,
"continuous intraoperative nerve monitoring":1,
"laryngeal adductor reflex":1,
"vagal schwannoma":1,
"vagus nerve":1,
"the Bethesda System for Reporting Thyroid Cytopathology":1,
"Go terms":1,
"differential expression networks":1,
"ego genes":1,
"gastric cancer (GC)":1,
"EMT":2,
"HIF1α":1,
"IQGAP1":1,
"VEGF-A":1,
"survival":2,
"timing":1,
"Italy":1,
"classification":2,
"cytopathology":3,
"Psammoma bodies":1,
"papillary carcinoma lung":1,
"pericardial effusion":1,
"malignant":1,
"teratoma":1,
"thyroid":7,
"Multidisciplinary therapies":1,
"Prognostic factors":1,
"Spinal metastases":1,
"Surgery":4,
"Survival analysis":1,
"Granular cell tumor":1,
"Pituicytoma":1,
"Pituitary":1,
"Sellar tumors":1,
"Spindle cell oncocytoma":1,
"TTF-1":1,
"Anaplastic thyroid cancer":5,
"Malignancy risk":1,
"TI-RADS":1,
"PROMIS":1,
"bone metastases":1,
"pain":1,
"physical function":1,
"Destructive thyroiditis":1,
"Hepatocellular carcinoma":1,
"LAMC2":1,
"MYO1G":1,
"lymph node metastases":2,
"quantitative proteomics":1,
"Spatial heterogeneity":1,
"TERT":2,
"adenoma":1,
"endoscopic":1,
"hyperparathyroidism":2,
"parathyroid":1,
"papillary carcinoma":4,
"radioiodine treatment":1,
"whole-body scan":1,
"Fractures":1,
"Osteoporosis":1,
"Veterans":1,
"ACR TI-RADS":1,
"malignancy":2,
"thyroid calcifications":1,
"Cholesterol metabolism":1,
"Dendrogenin A":1,
"Differentiation":2,
"Tumor-suppressor":1,
"phase 2":1,
"radioactive iodine (RAI)-refractory":1,
"vascular endothelial growth factor receptor (VEGF) Trap":1,
"Glioma growth":1,
"Glycolysis":1,
"LINC00689":1,
"miR-338-3p":1,
"Autoimmunity":1,
"Graves' disease":1,
"IFNγ":1,
"Immune checkpoints":2,
"PD-1":2,
"PD-L1":1,
"PD-L2":1,
"T-Lymphocytes":1,
"Tolerances":1,
"Hurthle cell neoplasm":1,
"medullary carcinoma":1,
"cold nodule":1,
"hot nodule":1,
"warm nodule":1,
"Colorectal cancer –reproductive outcomes":1,
"Drinking water":1,
"Economic analysis":1,
"Nitrate":1,
"head and neck squamous cell carcinoma metastasis":1,
"metastasis to thyroid":1,
"secondary squamous cell carcinoma of thyroid":1,
"Elastography":1,
"ltrasound":1,
"Fusion imaging":1,
"Iodine-124":1,
"Positron emission tomography":1,
"Antiangiogenic":1,
"Molecular biology":1,
"Network":1,
"Radioiodine-refractory differentiated thyroid carcinoma":1,
"TUTHYREF":1,
"Target therapy":2,
"Bethesda classification":1,
"gene expression classifier":1,
"Bethesda system III/IV":1,
"US-FNA":1,
"ultrasound characteristics":1,
"EZ-Blocker":1,
"Intraoperative monitoring":1,
"One-lung ventilation":1,
"Recurrent laryngeal nerve":2,
"Thoracic surgery":1,
"Ectopic papillary carcinoma":1,
"Floor of mouth":1,
"Reconstruction":1,
"Tensor fascia lata":1,
"Thyroglossal duct tract":1,
"Extrathyroidal extension":2,
"TTF1":2,
"CASTLE":2,
"carcinoma showing thymic-like differentiation":1,
"esophageal resection":1,
"suprahyoid release":1,
"tracheal reconstruction":2,
"tracheal resection":1,
"Antitumor activity":1,
"Apoptosis":1,
"Released polysaccharides (RPS)":1,
"Sulfated polymer":1,
"Synechocystis":1,
"FBXL19":1,
"HECW1":1,
"different cell types":1,
"ubiquitination":1,
"esophageal reconstruction":1,
"free bipaddled posterior tibial artery perforator flap":1,
"simultaneous reconstruction":1,
"Bethesda system":3,
"FNA":2,
"molecular testing":5,
"risk of malignancy":2,
"thyroid cytology":1,
"Bladder":1,
"Carcinome urothélial":1,
"Cytologie urinaire":1,
"Urinary cytology":1,
"Urothelial carcinoma":1,
"Vessie":1,
"PD0325901":1,
"PLX51107":1,
"bromodomain and extraterminal protein inhibitor":1,
"tumorigenesis":1,
"Calcitonin":1,
"Medullary thyroid carcinoma":5,
"Radiofrequency ablation":1,
"Isoforms":1,
"Normal thyroid":1,
"RET":3,
"Biomarker":1,
"Gene Expression Omnibus":1,
"Weighted gene co-expression network analysis":1,
"C cell hyperplasia":1,
"C cells":1,
"RAI refractory":1,
"Real life":1,
"BRAFV600E":1,
"Diagnostic accuracy":1,
"Systematic review":2,
"CCND1":1,
"NR2F1-AS1":1,
"miRNA-338-3P":1,
"Atypia of undetermined significance/follicular lesion of undetermined significance":1,
"Bethesda":1,
"Follicular neoplasm/suspicious for follicular neoplasm":1,
"Noninvasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP)":1,
"Fukushima":1,
"Japanese Black":1,
"cattle":1,
"thyroid gland":3,
"metastatic thyroid cancer":1,
"molecular profiling":1,
"poorly differentiated thyroid cancer":2,
"radioactive iodine refractory":1,
"neonatal outcomes":1,
"pregnancy":3,
"pregnancy outcomes":1,
"Diabetes":1,
"Lymphoma":1,
"Metformin":1,
"Pancreatic cancer":2,
"Advanced thyroid cancer":1,
"Distant metastases":1,
"Radioiodine refractory":1,
"Unusual metastases":1,
"biochemical recurrence/persistent disease":1,
"clinicopathological factor":1,
"programmed death-ligand 1":1,
"structural recurrence":1,
"DNA methylation":1,
"bisulfite-pyrosequencing":1,
"diagnostic markers":1,
"follicular thyroid carcinoma":1,
"NIFTP":1,
"Non-invasive follicular thyroid neoplasm with papillary-like nuclear features":1,
"Cadmium":1,
"Cd/Se ratio":1,
"Trace metals (endocrine disrupters)":1,
"TSH":1,
"Head and neck cancer":1,
"Lipid metabolism":1,
"Obesity":2,
"Oncology":2,
"Cell migration and invasion":1,
"Cofilin":1,
"Cytoskeleton":1,
"RPI-1":1,
"ablation":1,
"contrast media":1,
"radiofrequency":1,
"neoplasm":1,
"GLIS3":1,
"PAX-GLIS3":1,
"fusion":1,
"hyalinizing trabecular tumor (HTT)":1,
"next-generation sequencing":1,
"chemotherapy":1,
"controlled drug release":1,
"nanomedicines":1,
"photothermal therapy":1,
"refractory thyroid cancer":1,
"theranostics":1,
"BRAFV600E mutation":2,
"fine-needle aspiration cytology":2,
"polymerase chain reaction":1,
"angioinvasion":1,
"poorly differentiated thyroid carcinoma":1,
"widely invasive":1,
"Adénome thyréotrope":1,
"Hyperthyroïdie":1,
"Pit-1":1,
"Pituitary tumor":1,
"Somatostatin analogs":1,
"TSH adenoma":1,
"TSH-secreting tumor":1,
"Tumeur hypophysaire":1,
"Tumeur thyréotrope":1,
"Incidence":3,
"Incidence du cancer thyroïdien":1,
"Incidence of thyroid cancer":1,
"Microcarcinome papillaire":1,
"Micropapillary carcinoma":1,
"Registre des cancers thyroïdiens":1,
"Standardized incidence rate":1,
"Taux incidence standardisée":1,
"Thyroid cancer registry":1,
"Malignant transformation":1,
"Mature cystic teratoma":1,
"Bethesda III/IV nodule":1,
"cost-effectiveness":1,
"diagnostic lobectomy":1,
"MEK1 mutations":1,
"RAS-like":1,
"ARHI":1,
"imprinted gene":1,
"CTLA-4":1,
"hypophysitis":1,
"immune-related adverse events":1,
"immunotherapy":3,
"Forecasting":1,
"Lymphatic metastasis":1,
"Benign thyroid nodule":1,
"Microwave ablation":1,
"Papillary thyroid microcarcinoma":2,
"5-hydoxymethylcytosine":1,
"biological marker":1,
"epigenetics":1,
"case parameters":1,
"deleted in malignant brain tumors":1,
"phosphoinositide-dependent protein kinase 1":1,
"contrast-enhanced ultrasound":1,
"two-dimensional ultrasound":1,
"polycystic kidney and hepatic disease 1-like 1":1,
"Mts1":1,
"endocrine cancer":1,
"prognostic factor":1,
"(131)I-NaI activity":1,
"Dosimetry":1,
"Pharmacokinetics":1,
"Thyroid remnants":1,
"GLIS Krüppel-like zinc finger proteins":1,
"chromosomal translocation":1,
"leukemogenesis":1,
"oncogenesis":1,
"transcription":1,
"Growth hormone secreting adenomas":1,
"Thyroid disease":1,
"RET/PTC":1,
"driver mutation":1,
"molecular signature":1,
"radiation":1,
"FAPI":1,
"PSMA":1,
"neuroendocrine tumor":2,
"neurotensin":1,
"radionuclide therapy":1,
"theranostic":1,
"BMS-986253":1,
"Clinical trial":1,
"HuMax-IL8":1,
"Immune assays":1,
"Interleukin-8 (IL-8)":1,
"Metastatic cancer":1,
"Monoclonal antibody":1,
"American Joint Committee on Cancer (AJCC)":1,
"Differentiated thyroid cancer (DTC)":1,
"Fine needle aspiration cytology (FNAC)":1,
"TSH levels":1,
"Thyroid antibody levels":1,
"thyroid neoplasm":2,
"vitamin D level":1,
"gene panel":1,
"genetic testing of thyroid nodules":1,
"génpanel":1,
"new generation sequencing":1,
"pajzsmirigydaganatok":1,
"pajzsmirigygöbök genetikai vizsgálata":1,
"thyroid tumors":1,
"újgenerációs szekvenálás":1,
"Artificial intelligence in ultrasound":1,
"breast lesion":1,
"deep learning in ultrasound":1,
"liver lesion":1,
"ACTH independent hypercortisolism":1,
"parathyroid cancer":1,
"Parathyroid adenoma":1,
"carcinoma":1,
"differentiated thyroid cancer":2,
"immune cells":1,
"macrophages":1,
"mast cells":1,
"neutrophils":1,
"tumor microenvironment":1,
"Korea National Health and Nutrition Examination Survey":1,
"cancer survivors":1,
"hand strength":1,
"neoplasms":2,
"Lobectomy":1,
"VUS":1,
"genetic screening":1,
"exosomes":1,
"heat shock proteins (Hsp)":1,
"molecular chaperones":1,
"PBX3":1,
"miR-129-5p":1,
"MALDI-MSI":1,
"proteomics":1,
"health services administration &amp":1,
"management":1,
"pathology":1,
"primary care":1,
"public health":1,
"radiology &amp":1,
"imaging":1,
"ACTN4":1,
"HCC":1,
"TRIP13":1,
"miR-192-5p":1,
"Intraoperative nerve monitoring":1,
"Follicular carcinoma":2,
"Malignant struma ovarii":1,
"PPARgamma":1,
"clinical trials":1,
"mTOR inhibitors":1,
"medullary thyroid cancer":1,
"molecular alterations":1,
"radioactive iodine resistance":1,
"targeted therapy":1,
"tyrosine kinase inhibitors":1,
"gene rearrangements":1,
"pediatric thyroid cancer":1,
"targeted cancer therapy":1,
"Diagnostic techniques and procedures":1,
"personalized medicine":2,
"thyroid cancers":1,
"Golgi phosphoprotein 3":1,
"Neoplasm metastasis":1,
"aerobic glycolysis":1,
"esophageal cancer cell":1,
"pyruvate kinase muscle isozyme 2 (PKM2)":1,
"vacuolar H+-ATPase subunit V0C":1,
"Component analysis":1,
"Kazakhstan":1,
"computed tomography":1,
"nomograms":1,
"tumor staging":1,
"Contrast enhanced CT scan":1,
"TIRADS":1,
"TNM staging":1,
"Central compartment lymph node dissection":1,
"Central compartment lymph nodes":1,
"Fine needle aspiration cytology":1,
"Histopathological examination":1,
"Total thyroidectomy":1,
"Well-differentiated thyroid malignancy":1,
"FT-UMP":1,
"clinical screening":1,
"promoter mutation":1,
"NF-kB":1,
"cell cycle":1,
"triple-negative breast cancer cells":1,
"Isotopes":1,
"Sodium-iodide symporter":1,
"HMGA2":1,
"ZFAS1":1,
"ceRNA":2,
"miR-590-3p":1,
"progression":1,
"lymph node metastasis":1,
"lymphocyte-to-monocyte ratio":1,
"DNM3":1,
"linc01278":1,
"lateral neck dissection":1,
"skip metastasis":1,
"Atypia of undetermined significance":1,
"follicular lesion of undetermined significance":1,
"AURKB":1,
"GESA":1,
"TCGA database":1,
"ccRCC":1,
"machine-learning":1,
"noninvasive follicular thyroid neoplasm with papillary-like nuclear features":1,
"support vector machine":1,
"Gingiva":1,
"Lymph node":2,
"Squamous cell carcinoma":1,
"Merkel cell carcinoma":1,
"head and neck":1,
"neck lymph node dissection":1,
"Iodine Radioisotopes":1,
"Molecular Imaging":1,
"ACTH syndrome":1,
"Ectopic":1,
"Medullary":1,
"LT4 treatment":1,
"ergodicity":1,
"intra-class correlation":1,
"response heterogeneity":1,
"setpoint":1,
"thyroid homeostasis":1,
"SEER database":2,
"epidemiology":1,
"Columnar cell":1,
"mortality":1,
"propensity score matching analysis":1,
"central lymph node metastasis":1,
"BRAF mutation":1,
"Melanoma":1,
"thyroid stimulating hormone":2,
"Chordoma":1,
"Notochord":1,
"SMARCB1 Protein":1,
"fineneedleaspirationcytology":1,
"papillarythyroidcarcinoma":1,
"prophylacticnodedissection":1,
"surgeon-performedultrasound":1,
"hypocalcemia":1,
"hypoparathyroidism":1,
"CRP":1,
"anaplastic":1,
"ferritin":1,
"inflammatorymarkers":1,
"Gd3+":1,
"MR molecular imaging":1,
"SHP2":1,
"nanoparticles":1,
"thyroid tumor":1,
"SDHAF2, thyroid":1,
"carotid body":1,
"neoplasia":1,
"paraganglioma":1,
"TMTP1":1,
"cervical cancer":1,
"micelles":1,
"near-infrared imaging":1,
"sentinel lymph node":1,
"cancer of unknown primary":1,
"cancer of unknown primary site":1,
"metastatic cancer of unknown primary site":1,
"primary cancer of unknown origin":1,
"Hashimoto's thyroiditis":1,
"thyroid hormones":1,
"Deep convolutional neural network (DCNN)":1,
"Inception-ResNet-v2":1,
"VGG-19":1,
"diagnostic efficiency":1,
"central lymph node dissection (central LND)":1,
"central lymph node metastasis (LNM)":1,
"clinicopathological features":1,
"Adenoid cystic carcinoma":1,
"laryngeal tumor":1,
"minor salivary gland cancer":1,
"GSK1059615":1,
"Glucose restriction":1,
"MCF-7":1,
"MDA-MB 231":1,
"mTOR":1,
"BRAF V600E gene":1,
"Blood cell count":1,
"Inflammation":1,
"Mean platelet volume":1,
"YN968D1":1,
"antiangiogenesis drug":1,
"cervix carcinoma":1,
"efficacy":1,
"safety":1            };
            var data = [];
            for (var name in keywords) {
                data.push({
                    name: name,
                    value: Math.sqrt(keywords[name])
                })
            }
            var maskImage = new Image();
            var option = {
	             title: {
                text: '2019年9月论文keyword词云'
            },
                series: [ {
                    type: 'wordCloud',
                    sizeRange: [15, 100],
                    rotationRange: [-90, 90],
                    rotationStep: 45,
                    gridSize: 2,
                    shape: 'pentagon',
                    maskImage: maskImage,
                    drawOutOfBound: false,
                    textStyle: {
                        normal: {
                            color: function () {
                                return 'rgb(' + [
                                    Math.round(Math.random() * 160),
                                    Math.round(Math.random() * 160),
                                    Math.round(Math.random() * 160)
                                ].join(',') + ')';
                            }
                        },
                        emphasis: {
                            color: 'red'
                        }
                    },
                    data: data.sort(function (a, b) {
                        return b.value  - a.value;
                    })
                } ]
            };
            maskImage.onload = function () {
                option.series[0].maskImage
                chart.setOption(option);
            }
            maskImage.src = 'data:image/png;base64,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';
            window.onresize = function () {
                chart.resize();
            }
        </script>
    </body>
</html>
